We are live on ! Find out more
VP

venBio Partners Portfolio holdings

AUM $281M
1-Year Est. Return 261.03%
This Fund
S&P 500
This Quarter Est. Return
+35.22%
1 Year Est. Return
+261.03%
3 Year Est. Return
+648.19%
5 Year Est. Return
+623.84%
10 Year Est. Return
AUM
$276M
AUM Growth
+$95.9M
Cap. Flow
+$36.2M
Cap. Flow %
13.11%
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
2
Reduced
1
Closed

Top Sells

1
VTYX
Ventyx Biosciences
VTYX
+$64.6M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLRN
1
DELISTED
ACELYRIN
SLRN
$80.6M 29.18%
+3,857,230
New +$78.9M
ALXO icon
2
ALX Oncology
ALXO
$264M
$72.8M 26.36%
9,699,925
PHVS icon
3
Pharvaris
PHVS
$2.35B
$64.6M 23.37%
4,264,672
+1,986,097
+87% +$19.2M
HRMY icon
4
Harmony Biosciences
HRMY
$1.93B
$36.4M 13.19%
1,035,396
VTYX
5
DELISTED
Ventyx Biosciences
VTYX
$13.9M 5.03%
424,032
-1,874,801
-82% -$64.6M
ELEV
6
DELISTED
Elevation Oncology
ELEV
$4.43M 1.6%
2,914,255
+1,047,916
+56% +$2.76M
IMPL
7
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$3.5M 1.27%
2,759,791

Similar funds